Assertio Holdings, Inc. Announces Pricing of $34.3 Million Registered Direct OfferingGlobeNewsWire • 02/10/21
Assertio Holdings, Inc. Announces Closing of Registered Direct Offering of $14 MillionGlobeNewsWire • 02/09/21
Assertio Holdings, Inc. Announces Pricing of $14 Million Registered Direct OfferingGlobeNewsWire • 02/05/21
Assertio Announces $5.0 Million Insurance Settlement and General Corporate UpdatesGlobeNewsWire • 02/03/21
Are Options Traders Betting on a Big Move in Assertio Holdings (ASRT) Stock?Zacks Investment Research • 01/12/21
Assertio Announces Transfer of Listing from Nasdaq Global Select Market to Nasdaq Capital MarketGlobeNewsWire • 12/29/20
Assertio to Present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020GlobeNewsWire • 11/10/20
Assertio Holdings, Inc. (ASRT) CEO Todd Smith on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/06/20
Assertio to Present at Cantor Virtual Global Healthcare Conference on September 16, 2020GlobeNewsWire • 09/09/20
Assertio Holdings, Inc. (ASRT) CEO Todd Smith on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/08/20
Analysts Estimate Assertio (ASRT) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/31/20
Assertio to Release Second Quarter 2020 Financial Results and Host Webcast on August 7, 2020GlobeNewsWire • 07/20/20
Assertio Therapeutics, Inc. (ASRT) CEO Arthur Higgins on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/11/20
Assertio Therapeutics Announces Completion and Final Results of the Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes due 2021 and 5.00% Senior Convertible Notes due 2024GlobeNewsWire • 04/08/20
Assertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain ProductsGlobeNewsWire • 03/16/20
Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024GlobeNewsWire • 03/11/20
Assertio Therapeutics, Inc. (ASRT) CEO Arthur Higgins on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/09/20